Full Professor
Strategic program(s):
Biography
Prof. Janneke van de Wijgert, MD PhD MPH, is a translational infectious disease researcher, educated in biomedical sciences and medicine (Utrecht University, Netherlands), and public health epidemiology (University of California at Berkeley, USA). Her work experience includes clinical epidemiological and public health research, laboratory research, and product development worldwide. Former employers include the University of California at San Francisco (5 years of which as Director of the UZ-UCSF Collaborative HIV Research Program in Harare, Zimbabwe), the Population Council in New York, the Amsterdam University Medical Center, and the University of Liverpool, UK. She was appointed Full Professor in the Julius Center for Health Sciences and Primary Care of the University Medical Center (UMC) Utrecht in 2017, and served as Chief Science Officer at the Dutch Institute of Public Health and the Environment (RIVM) from 2022-2024. She has supervised/is supervising multiple PhD and Master's students, and has published more than 200 peer-reviewed papers.
Janneke van de Wijgert’s main areas of research and teaching include 1) general infectious and immune-mediated disease epidemiology (including COVID-19 and post-COVID); 2) the role of the human microbiome in health and disease; 3) the role of the urinary tract microbiome in urinary tract infections; 4) the role of the cervicovaginal microbiome in reproductive and neonatal health and disease, and in prevention of HIV transmission; and 5) evaluation of diagnostics, treatments, and prevention interventions in these areas. In addition to traditional epidemiological approaches, she has specialised in incorporating ‘-omics’ and other complex biological data into epidemiological models. During the COVID-19 epidemic, she has worked with eHealth applications to control epidemic spread as well as vaccination and diagnostic studies. She is currently the PI of the RECLAIM post-COVID adaptive platform trial in the Netherlands and the UTIr cohort study.
A complete list of publications can be found on ORCID: https://orcid.org/0000-0003-2728-4560
Research aim
To optimise prevention, diagnosis, prognosis and management of common infections in general practice.Research aim
To improve prevention, diagnosis and treatment of infectious diseases and to establish an international research infrastructure for a rapid scientific response in the face of a new infectious disease threat.Research aim
Our aim is to translate human microbiome knowledge to improved diagnostic tests and clinical interventions by incorporating systems biology into clinical epidemiological studies, conducting mechanistic laboratory studies, and linking the two.Peer reviewer, invited speaker, session chair, scientific advisory committee member, advisor - Academic peer review or advise. Unpaid, reimbursement for expenses, and/or nominal fees. - Multiple organisations
